Literature DB >> 31006550

The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Daniel Weintraub1, Eugenia Mamikonyan2.   

Abstract

Affective disorders, cognitive decline, and psychosis have long been recognized as common in Parkinson disease (PD), and other psychiatric disorders include impulse control disorders, anxiety symptoms, disorders of sleep and wakefulness, and apathy. Psychiatric aspects of PD are associated with numerous adverse outcomes, yet in spite of this and their frequent occurrence, there is incomplete understanding of epidemiology, presentation, risk factors, neural substrate, and management strategies. Psychiatric features are typically multimorbid, and there is great intra- and interindividual variability in presentation. The hallmark neuropathophysiological changes that occur in PD, plus the association between exposure to dopaminergic medications and certain psychiatric disorders, suggest a neurobiological basis for many psychiatric symptoms, although psychological factors are involved as well. There is evidence that psychiatric disorders in PD are still under-recognized and undertreated and although psychotropic medication use is common, controlled studies demonstrating efficacy and tolerability are largely lacking. Future research on neuropsychiatric complications in PD should be oriented toward determining modifiable correlates or risk factors and establishing efficacious and well-tolerated treatment strategies.
Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Parkinson disease; cognition; dementia; depression; impulse control disorder; psychosis

Year:  2019        PMID: 31006550      PMCID: PMC7015280          DOI: 10.1016/j.jagp.2019.03.002

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  358 in total

1.  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.

Authors:  Claire Ardouin; Valerie Voon; Yulia Worbe; Nehman Abouazar; Virginie Czernecki; Hassan Hosseini; Antoine Pelissolo; Elena Moro; Eugénie Lhommée; Anthony E Lang; Yves Agid; Alim-Louis Benabid; Pierre Pollak; Luc Mallet; Paul Krack
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

2.  Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease.

Authors:  Marta Kaminska; Victoria P Mery; Anne-Louise Lafontaine; Ann Robinson; Andrea Benedetti; Priti Gros; R John Kimoff
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

3.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

4.  Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.

Authors:  L M Chahine; S X Xie; T Simuni; B Tran; R Postuma; A Amara; W H Oertel; A Iranzo; C Scordia; M Fullard; C Linder; R Purri; A Darin; L Rennert; A Videnovic; P Del Riva; D Weintraub
Journal:  Parkinsonism Relat Disord       Date:  2016-03-12       Impact factor: 4.891

5.  A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Authors:  I H Richard; M P McDermott; R Kurlan; J M Lyness; P G Como; N Pearson; S A Factor; J Juncos; C Serrano Ramos; M Brodsky; C Manning; L Marsh; L Shulman; H H Fernandez; K J Black; M Panisset; C W Christine; W Jiang; C Singer; S Horn; R Pfeiffer; D Rottenberg; J Slevin; L Elmer; D Press; H C Hyson; W McDonald
Journal:  Neurology       Date:  2012-04-11       Impact factor: 9.910

6.  Longitudinal study of normal cognition in Parkinson disease.

Authors:  Kara Pigott; Jacqueline Rick; Sharon X Xie; Howard Hurtig; Alice Chen-Plotkin; John E Duda; James F Morley; Lama M Chahine; Nabila Dahodwala; Rizwan S Akhtar; Andrew Siderowf; John Q Trojanowski; Daniel Weintraub
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

Review 7.  Non motor subtypes and Parkinson's disease.

Authors:  Anna Sauerbier; Peter Jenner; Antoniya Todorova; K Ray Chaudhuri
Journal:  Parkinsonism Relat Disord       Date:  2015-09-11       Impact factor: 4.891

8.  Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.

Authors:  Kara M Smith; Sharon X Xie; Daniel Weintraub
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-03       Impact factor: 10.154

Review 9.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

10.  Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.

Authors:  Joseph H Friedman; James C Beck; Kelvin L Chou; Gracia Clark; Christopher P Fagundes; Christopher G Goetz; Karen Herlofson; Benzi Kluger; Lauren B Krupp; Anthony E Lang; Jao-Shin Lou; Laura Marsh; Anne Newbould; Daniel Weintraub
Journal:  NPJ Parkinsons Dis       Date:  2016-01-14
View more
  24 in total

1.  Alexithymia, depression, and cognition in patients with Parkinson's disease.

Authors:  Gulay Kenangil; Mehmet Demir; Esma Tur; Fusun Domac
Journal:  Acta Neurol Belg       Date:  2021-01-16       Impact factor: 2.396

2.  High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice.

Authors:  Devlina Ghosh; Aditi Singh; Alok Kumar; Neeraj Sinha
Journal:  Immunol Res       Date:  2022-06-07       Impact factor: 4.505

3.  Updates in Geriatric Psychiatry.

Authors: 
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-07-09

4.  Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses.

Authors:  Sarah M Szymkowicz; Jacob D Jones; Holly Timblin; Cameron A Ryczek; Warren D Taylor; Pamela E May
Journal:  Am J Geriatr Psychiatry       Date:  2021-11-21       Impact factor: 7.996

Review 5.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

6.  Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.

Authors:  Zhi Zhou; Martijn L T M Müller; Prabesh Kanel; Jason Chua; Vikas Kotagal; Daniel I Kaufer; Roger L Albin; Kirk A Frey; Nicolaas I Bohnen
Journal:  Neurology       Date:  2019-11-15       Impact factor: 9.910

7.  Attentional dysfunction and the punding spectrum in Parkinson's disease.

Authors:  Jared T Hinkle; Kate Perepezko; Kelly A Mills; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2021-01-30       Impact factor: 4.891

8.  Psychomotor processing and functional decline in Parkinson's disease predicted by the Purdue Pegboard test.

Authors:  Jared T Hinkle; Gregory M Pontone
Journal:  Int J Geriatr Psychiatry       Date:  2021-02-02       Impact factor: 3.850

9.  Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson's Disease.

Authors:  Camilla Elefante; Giulio Emilio Brancati; Silvia Bacciardi; Sonia Mazzucchi; Eleonora Del Prete; Giovanni Palermo; Daniela Frosini; Ubaldo Bonuccelli; Roberto Ceravolo; Lorenzo Lattanzi; Icro Maremmani; Giulio Perugi
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

10.  Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?

Authors:  Thanh Phuong Pham Nguyen; Danielle S Abraham; Dylan Thibault; Daniel Weintraub; Allison W Willis
Journal:  BMC Neurol       Date:  2021-06-24       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.